“The idea that the MAA is being held up for EDEN is, and always has been, total quackery.”
— the likes of Guru Gary, Doc Logic, and other minions of LP & LG, who have been broadcasting this are a bunch of liars just like LP and LG. Regulatory agencies will never hold up an approval due to volume, particularly when it’s a novel immunotherapy vaccine. KITE could only produce doses for 100 patients in the first year post FDA approval. Many such examples.
However, what it indicates is that be prepared for a long delay on UK approval. That’s what LP & LG are coaching the minions to position the shareholder expectations in terms of UK approval. Since even Doc logic does not expect Flaskworks to be commercially approved for another year. Personally, I don’t think Flasworks commercial approval will happen in 2026. In fact, we’d be lucky to have it in 2027 given NWBO’s pace.